Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 28, 2014; 20(40): 14559-14567
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14559
Hepatitis B virus and hepatitis C virus dual infection
Gaia Caccamo, Francesca Saffioti, Giovanni Raimondo
Gaia Caccamo, Francesca Saffioti, Giovanni Raimondo, Division of Clinical and Molecular Hepatology, Department of Internal Medicine, University Hospital of Messina, 98124 Messina, Italy
Author contributions: Caccamo G and Raimondo G wrote and revised the paper; Saffioti F contributed to the bibliographic research and revised the paper.
Correspondence to: Giovanni Raimondo, MD, Professor, Chief, Division of Clinical and Molecular Hepatology, Department of Internal Medicine, University Hospital of Messina, Via Consolare Valeria 1, 98124 Messina, Italy. raimondo@unime.it
Telephone: +39-90-2212392 Fax: +39-90-2213594
Received: October 29, 2013
Revised: March 24, 2014
Accepted: May 19, 2014
Published online: October 28, 2014
Processing time: 364 Days and 20.8 Hours
Abstract

Hepatitis B virus (HBV) and hepatitis C virus (HCV) share common mode of transmission and both are able to induce a chronic infection. Dual HBV/HCV chronic coinfection is a fairly frequent occurrence, especially in high endemic areas and among individuals at high risk of parenterally transmitted infections. The intracellular interplay between HBV and HCV has not yet been sufficiently clarified, also due to the lack of a proper in vitro cellular model. Longitudinal evaluation of serum HBV DNA and HCV RNA amounts has revealed that complex virological profiles may be present in coinfected patients. Dual HBV/HCV infection has been associated to a severe course of the liver disease and to a high risk of developing hepatocellular carcinoma. Despite the clinical importance, solid evidence and clear guidelines for treatment of this special population are still lacking. This review summarizes the available data on the virological and clinical features as well as the therapeutic options of the dual HBV/HCV infection, and highlights the aspects that need to be better clarified.

Keywords: Hepatitis B virus/hepatitis C virus coinfection; Chronic hepatitis; Viral interaction; Cirrhosis; Hepatocellular carcinoma; Antiviral therapy

Core tip: This review analyses the available virological and clinical data about the dual hepatitis B virus/hepatitis C virus infection. In particular, it highlights the aspects concerning the possible viral interactions, the impact on liver disease progression and hepatocellular carcinoma development as well as the therapeutic options in this special population.